NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

FREDUN PHARMACEUTICALS LTD.

NSE : NABSE : 539730ISIN CODE : INE194R01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE774.55-14.75 (-1.87 %)
PREV CLOSE ( ) 789.30
OPEN PRICE ( ) 791.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4540
TODAY'S LOW / HIGH ( )761.15 815.00
52 WK LOW / HIGH ( ) 6501249
NSE
This Company is not listed in NSE
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 08-06 1987
Management Info
Daulat N Medhora - Chairman Fredun N Medhora - Managing Director
Registered Office

Address 11th Floor, Tower A,Urmi Estate 95, Ganpatrao Kadam Marg,Lower Parel (W),
Mumbai,
Maharashtra-400013

Phone 022-40318111

Email business@fredungroup.com

Website www.fredungroup.com

Registrars Details
Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
 Listing : BSE
NEWS
22Mar Allotment of Convertible warrants
Preferential Issue of shares Inter alia, pursuant to the approval of Sh..
22Mar Allotment of Equity Shares
Preferential Issue of shares Inter alia, pursuant to the approval of Sh..
12Feb Fredun Pharmaceuticals gets orders wor
Fredun Pharmaceuticals has received large orders from Southeast Asian (S..
12Feb Fredun Pharmaceuticals informs about p
Fredun Pharmaceuticals has informed that it enclosed press release title..
19Jan Fredun Pharmaceuticals informs about v
Fredun Pharmaceuticals has informed that it enclosed the Voting Results..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit42.2100000000001108.07
Gross Profit 57.6300000000001 175.09
Operating Profit 105.15296
Net Sales 870.082764.98
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
NGL Fine-Chem (BSE)
 2542.60 (12.29%)
M.Cap (Rs. in Cr)1570.82
Neuland Laboratories (BSE)
 7654.80 (1.79%)
M.Cap (Rs. in Cr)9821.02
Mankind Pharma (BSE)
 2397.40 (5.05%)
M.Cap (Rs. in Cr)96037.07
Sanofi India (BSE)
 8470.70 (0.89%)
M.Cap (Rs. in Cr)19508.55
Solara Active Pharma (BSE)
 474.10 (12.15%)
M.Cap (Rs. in Cr)1706.58
MORE
Shareholding Pattern
NON-INSTITUTION 49.28%
PROMOTERS 49.13%
FI/BANKS/INSURANCE 1.6%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
Scheme NameHold(%)
No Data Found
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.